Sponsor

Blue Earth Therapeutics Ltd

Clinical research sponsor

Published trials4

Recruiting shown3

Roles2

SourceClinicalTrials.gov

Clinical trials

4 shown

Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionNCT05413850 · lead sponsor · 2022-07-20

RECRUITING

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate CancerNCT06516510 · lead sponsor · 2024-10-31

TERMINATED

ACTinium in Castrate-RESistant Prostate Cancer After LUTEtiumNCT07414940 · collaborator · 2026-04-13

RECRUITING

NeoAdjuvant Theranostic Lutetium Study: The Nautilus TrialNCT06066437 · collaborator · 2024-03-29

RECRUITING

Sponsor roles

collaborator2

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.